Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03405155
Title Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Cancer Center at Thomas Jefferson University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Columbia University New York New York 10032 United States Details
Univeristy of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field